SALA ISABELLA MARIA

Sala, I (2026). Random forest regression for predicting healthcare costs using administrative databases. (Tesi di dottorato, , 2026). Dettaglio

Conforti, F., Pala, L., Catania, C., Zucali, P., Sala, I., Perrino, M., et al. (2025). Avelumab combined with axitinib for patients with advanced thymoma B3 and thymic carcinoma. CANCER, 131(18 (15 September 2025)) [10.1002/cncr.70092]. Dettaglio

Pala, L., Merlo, F., Sala, I., Pagan, E., Oriecuia, C., Specchia, C., et al. (2025). Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 117(8), 1557-1564 [10.1093/jnci/djaf049]. Dettaglio

Conforti, F., Holtschmidt, J., Nekljudova, V., Sala, I., Pagan, E., Solbach, C., et al. (2025). Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials. THE LANCET ONCOLOGY, 26(12), 1584-1597 [10.1016/S1470-2045(25)00546-7]. Dettaglio

Canonica, G., Blasi, F., Paggiaro, P., Heffler, E., Braido, F., Brussino, L., et al. (2025). Biologics as well as inhaled anti-asthmatic therapy achieve clinical remission: Evidence from the Severe Asthma Network in Italy (SANI). THE WORLD ALLERGY ORGANIZATION JOURNAL, 18(1) [10.1016/j.waojou.2024.101016]. Dettaglio